| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |